China on Friday announced the imposition of 34 per cent tariffs on all US goods. In retaliation to US President Donald ...

During its annual reconstitution, the Schwab ETF more than doubled its exposure to energy stocks. The fund boasts a ...

Because Nvidia (NASDAQ:NVDA) has become the face of artificial intelligence, investors tend to view it as a proxy for the ...

The sweeping tariffs President Donald Trump announced Wednesday have sent shock waves through the markets, prompting widespread selloffs. Some investors, however, are seeking refuge from the storm in ...

Comprehensive Analysis of Market Dynamics, Emerging Technologies, and ESG Trends Shaping the Future of Bioprocess Optimization and Digital Bio-manuf ...

While the probability of a recession has increased, we always get through it and the best businesses thrive. Unless directly ...

The £20,000 Stocks and Shares ISA limit will reset on 6 April. Smart investors could use current market volatility to their ...

U.S. soybean futures plunged after China levied a new 34% tariff on imported U.S. goods, of which soybeans are one of the ...

Dow and LyondellBasell downgraded at J.P. Morgan, as "petrochemical demand is faltering, raw material costs are rising, trade ...

DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.

Iovance Biotherapeutics (NasdaqGM:IOVA) experienced a 10% decline over the last week, amid market turbulence driven by escalating trade tensions and significant losses across major indexes. As broader ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...